Company · CIK 1346830
Tvardi Therapeutics, Inc.
| CIK | 1346830 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | TX |
| Listed | TVRD (Nasdaq) |
| First annual or quarterly report | 2014-03-28 |
Offerings
8 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-295496 | 2026-05-01 | 2026-07-17 | 3 | |
| 333-287675 | 2025-05-30 | 2026-05-13 | 4 | |
| 333-263165 | 2022-03-01 | 2024-06-07 | 3 | |
| 333-233666 | 2019-09-09 | 2019-09-09 | 1 | |
| 333-230333 | 2019-03-15 | 2019-07-25 | 4 | |
| 333-216657 | 2017-03-13 | 2018-07-20 | 6 | |
| 333-203072 | 2015-03-27 | 2015-07-30 | 4 | |
| 333-192230 | 2013-11-08 | 2014-02-03 | 5 |
Filings
32| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-17 | 424B5Shelf takedown | 333-295496 | 0001104659-26-084619 |
| 2026-05-13 | EFFECTDeclared effective | 333-287675 | 9999999995-26-001601 |
| 2026-05-12 | EFFECTDeclared effective | 333-295496 | 9999999995-26-001593 |
| 2026-05-01 | S-3Shelf registered | 333-295496 | 0001104659-26-054113 |
| 2025-10-20 | S-1/AAmendment | 333-287675 | 0001104659-25-100896 |
| 2025-10-07 | S-1/AAmendment | 333-287675 | 0001104659-25-097519 |
| 2025-05-30 | S-1Registration filed | 333-287675 | 0001104659-25-054853 |
| 2025-02-14 | EFFECTDeclared effective | 333-283900 | 9999999995-25-000462 |
| 2024-06-07 | 424B5Shelf takedown | 333-263165 | 0001104659-24-069643 |
| 2022-05-11 | EFFECTDeclared effective | 333-263165 | 9999999995-22-001411 |
| 2022-03-01 | S-3Shelf registered | 333-263165 | 0001104659-22-028775 |
| 2019-09-09 | S-3ASRShelf registered | 333-233666 | 0001193125-19-240408 |
| 2019-07-25 | 424B5Shelf takedown | 333-230333 | 0001193125-19-202585 |
| 2019-07-24 | 424B5Shelf takedown | 333-230333 | 0001193125-19-201291 |
| 2019-04-04 | EFFECTDeclared effective | 333-230333 | 9999999995-19-000605 |
| 2019-03-15 | S-3Shelf registered | 333-230333 | 0001193125-19-076767 |
| 2018-07-20 | 424B5Shelf takedown | 333-216657 | 0001193125-18-222540 |
| 2018-07-17 | 424B5Shelf takedown | 333-216657 | 0001193125-18-219822 |
| 2017-03-31 | 424B5Shelf takedown | 333-216657 | 0001193125-17-106495 |
| 2017-03-29 | 424B5Shelf takedown | 333-216657 | 0001193125-17-101741 |
| 2017-03-24 | EFFECTDeclared effective | 333-216657 | 9999999995-17-000653 |
| 2017-03-13 | S-3Shelf registered | 333-216657 | 0001193125-17-080383 |
| 2015-07-30 | 424B5Shelf takedown | 333-203072 | 0001193125-15-270848 |
| 2015-07-27 | 424B4Final prospectus | 333-203072 | 0001193125-15-264105 |
| 2015-05-13 | EFFECTDeclared effective | 333-203072 | 9999999995-15-001322 |
| 2015-03-27 | S-3Shelf registered | 333-203072 | 0001193125-15-109443 |
| 2014-02-03 | 424B4Final prospectus | 333-192230 | 0001193125-14-031425 |
| 2014-01-30 | EFFECTDeclared effective | 333-192230 | 9999999995-14-000256 |
| 2014-01-17 | S-1/AAmendment | 333-192230 | 0001193125-14-013561 |
| 2013-12-31 | S-1/AAmendment | 333-192230 | 0001193125-13-488240 |
| 2013-11-08 | S-1Registration filed | 333-192230 | 0001193125-13-435392 |
| 2013-10-04 | DRSDraft made public | 377-00337 | 0000950123-13-007723 |